OncoRevive

Accelerating Nature’s Manufacturing Machinery

OncoRevive

About

At OncoRevive, we specialize in early cancer detection through our advanced liquid biopsy technology, utilizing cutting-edge nanotechnology to revolutionize healthcare outcomes

Our Philosophy

At OncoRevive, a few drops of blood are all we need to keep a vigilant watch on your health

Our Philosophy

At OncoRevive, a few drops of blood are all we need to keep a vigilant watch on your health

Our Expertise

Our team of medical professionals has years of experience in their respective fields....

Our Expertise

Our team of medical professionals has years of experience in their respective fields....

Our Services

At OncoRevive, we're dedicated to comprehensive care every step of the way. ...

Our Services

At OncoRevive, we're dedicated to comprehensive care every step of the way. ...

OncoRevive

Story

1 Our Origin: The OncoRevive Genesis

OncoRevive began in 2023, driven by our team's 20 years of cancer research. Combining our expertise in nanotechnology and cancer, we aim to lead in early detection of cancer, offering a new hope for effective cancer care.

1 The Challenge: The Cancer Landscape

Every single minute, 87 cancer cases are diagnosed. This critical issue demands action and innovation. OncoRevive rose to meet this need, championing early detection of cancer through a simple but innovative blood test to shift the odds in our favor.

1 Our Mission: A Pledge To Save Lives

OncoRevive's mission is not only early detection of cancer but also monitoring treatment efficacy and recurrence, offering a transformative solution in the battle against cancer.

1 Innovation At Heart: Our Breakthrough Technology

OncoRevive leverages state-of-the-art nanotechnology that is significantly faster, more precise, and comprehensive compared with the existing methods, reducing costs by 40%. OncoRevive’s novel multiomics approach enables us to target wide ranges of key cancer biomarkers in the blood.

1 A Look Ahead: The Future With OncoRevive

OncoRevive will be a blood test kit combined with a pioneering AI-based software for ultra-early detection of cancer, aiming to identify cancer from nascent stage. This leap forward embodies our drive to enhance early detection and treatment outcomes.

OncoRevive

Testimonial

I'm Dr. Hosein from Peter MacCallum Cancer Center, specializing in cancer research for over 15 years. The breakthrough technology developed by Oncorevive shows great promise in cancer detection. Its innovative and straightforward approach is precisely what we need to detect cancer at its earliest stages, enabling more effective treatment for patients.

I'm Dr. Alisha Ramos from Northwestern University, USA, specializing in cancer research for over 15 years. The breakthrough technology developed by Oncorevive shows great promise in cancer detection. Its innovative and straightforward approach is precisely what we need to detect cancer at its earliest stages, enabling more effective treatment for patients.

Dr javid Wani. I believe that their diagnostics solution is based on an innovative multiplex platform technology, which is capable of seamlessly integrating the concepts of genomics, proteomics, and glycomics to profile biomarkers implicated in multiple cancers.